Clinical application of immunomonitoring in DCD donor kidney transplantation

Status

Active, not recruiting

Phases

Early Phase 1

Study type

Observational

Source

ChiCTR

Registry ID

ChiCTR2200056828

Enrollment

Unknown

Registered

2022-02-18

Start date

2022-02-16

Completion date

Unknown

Last updated

2023-09-11

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Kidney transplant

Interventions

case series:None

Eligibility

Sex/Gender

All

Age

18 Years to 75 Years

Inclusion criteria

Inclusion criteria: 1. Aged > 18 years; 2. First transplant.

Exclusion criteria

Exclusion criteria: Loss of transplanted kidney function within one year.

Design outcomes

Primary

Measure	Time frame
HLA antigen-specific memory B cells and HLA antibodies;The types and quantities of cytokines released by T cells were measured;Proportion of NK cell KIR genotype and NKG2C+ immunophenotype;Lymphocyte subsets;TTV-DNA loads;	—

Countries

China

Contacts

Public ContactLi Jianjun

The Second Affiliated Hospital of Nanhua University

lijianjun9962@aliyun.com+86 13017349962

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026